PRASAD SUYASH
Insider CIK 1679129 · BOLD Senior VP & Chief Med Officer · TSHA CMO and Head of R&D
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TSHA Taysha Gene Therapies, Inc | S Sale | 2022-07-06 | 2022-07-07 | 8,956 | $3.79 | $33.9K | 530,589 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2022-07-05 | 2022-07-07 | 3,905 | $3.51 | $13.7K | 539,545 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2022-07-01 | 2022-07-01 | 23,923 | $3.53 | $84.4K | 543,450 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2022-06-30 | 2022-07-01 | 13,892 | $3.72 | $51.7K | 567,373 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2022-06-29 | 2022-07-01 | 12,324 | $3.81 | $47.0K | 581,265 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2022-04-06 | 2022-04-08 | 40,325 | — | $0 | 40,325 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2022-02-23 | 2022-02-25 | 80,650 | — | $0 | 80,650 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2021-07-01 | 2021-07-01 | 19,706 | $21.12 | $416.2K | 593,589 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2021-06-30 | 2021-07-01 | 13,374 | $21.42 | $286.5K | 619,997 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2021-06-30 | 2021-07-01 | 6,202 | $22.44 | $139.2K | 613,795 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2021-06-30 | 2021-07-01 | 500 | $23.70 | $11.8K | 613,295 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2021-06-29 | 2021-07-01 | 300 | $25.19 | $7.6K | 633,371 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2021-06-29 | 2021-07-01 | 3,862 | $24.46 | $94.5K | 633,671 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2021-06-29 | 2021-07-01 | 35,056 | $23.74 | $832.2K | 637,533 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2021-01-19 | 2021-01-20 | 80,000 | — | $0 | 80,000 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | C Conversion deriv | 2020-09-28 | 2020-09-30 | 3,529 | — | $0 | 0 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | C Conversion | 2020-09-28 | 2020-09-30 | 3,844 | — | $0 | 672,589 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award | 2020-09-23 | 2020-09-25 | 668,745 | — | $0 | 668,745 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | F Tax w/h | 2019-06-05 | 2019-06-07 | 757 | $37.31 | $28.2K | 17,479 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2019-05-13 | 2019-05-15 | 10,000 | — | $0 | 30,870 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-05-13 | 2019-05-15 | 54 | $37.72 | $2.0K | 18,236 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-05-13 | 2019-05-15 | 9,946 | $36.98 | $367.8K | 18,290 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2019-05-13 | 2019-05-15 | 10,000 | $0.79 | $7.9K | 28,236 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2019-02-25 | 2019-02-27 | 10,000 | — | $0 | 40,870 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2019-02-25 | 2019-02-27 | 10,000 | $0.79 | $7.9K | 28,236 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-02-25 | 2019-02-27 | 10,000 | $30.06 | $300.6K | 18,236 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2019-02-06 | 2019-02-08 | 48,750 | — | $0 | 48,750 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award | 2019-02-06 | 2019-02-08 | 17,500 | — | $0 | 18,236 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award | 2018-11-15 | 2018-11-16 | 736 | $19.64 | $14.5K | 736 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2018-10-01 | 2018-10-02 | 10,000 | — | $0 | 50,870 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-10-01 | 2018-10-02 | 200 | $36.32 | $7.3K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2018-10-01 | 2018-10-02 | 200 | $0.79 | $158 | 200 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-10-01 | 2018-10-02 | 3,900 | $37.82 | $147.5K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2018-10-01 | 2018-10-02 | 3,900 | $0.79 | $3.1K | 3,900 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-10-01 | 2018-10-02 | 4,699 | $35.60 | $167.3K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2018-10-01 | 2018-10-02 | 1,101 | $0.79 | $870 | 1,101 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-10-01 | 2018-10-02 | 100 | $39.52 | $4.0K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2018-10-01 | 2018-10-02 | 100 | $0.79 | $79 | 100 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2018-10-01 | 2018-10-02 | 4,699 | $0.79 | $3.7K | 4,699 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-10-01 | 2018-10-02 | 1,101 | $38.85 | $42.8K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2018-07-02 | 2018-07-05 | 5,011 | — | $0 | 60,870 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2018-07-02 | 2018-07-05 | 4,989 | — | $0 | 65,881 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-07-02 | 2018-07-05 | 4,989 | $38.02 | $189.7K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2018-07-02 | 2018-07-05 | 5,011 | $0.79 | $4.0K | 5,011 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-07-02 | 2018-07-05 | 5,011 | $38.79 | $194.4K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2018-07-02 | 2018-07-05 | 4,989 | $0.79 | $3.9K | 4,989 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2018-03-29 | 2018-03-29 | 7,800 | — | $0 | 70,870 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2018-03-29 | 2018-03-29 | 7,800 | $0.79 | $6.2K | 7,800 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2018-03-27 | 2018-03-28 | 300 | — | $0 | 78,670 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2018-03-27 | 2018-03-28 | 300 | $0.79 | $237 | 300 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2018-03-26 | 2018-03-28 | 1,900 | — | $0 | 78,970 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-26 | 2018-03-28 | 1,900 | $30.00 | $57.0K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2018-03-26 | 2018-03-28 | 1,900 | $0.79 | $1.5K | 1,900 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2017-12-01 | 2017-12-05 | 8,000 | — | $0 | 80,870 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2017-12-01 | 2017-12-05 | 6,770 | $0.79 | $5.3K | 6,770 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-12-01 | 2017-12-05 | 6,770 | $28.45 | $192.6K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2017-12-01 | 2017-12-05 | 1,230 | $0.79 | $972 | 1,230 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-12-01 | 2017-12-05 | 1,230 | $28.98 | $35.6K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2017-11-16 | 2017-11-17 | 75,000 | — | $0 | 75,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2017-09-01 | 2017-09-01 | 8,000 | — | $0 | 88,870 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-01 | 2017-09-01 | 8,000 | $21.44 | $171.5K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2017-09-01 | 2017-09-01 | 8,000 | $0.79 | $6.3K | 8,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-03-29 | 2018-03-29 | 7,800 | $30.03 | $234.2K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-03-27 | 2018-03-28 | 300 | $30.00 | $9.0K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2017-01-25 | 2017-01-27 | 70,000 | — | $0 | 70,000 | SEC↗ |